These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 37347386)

  • 21. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa.
    Chetty S; Baalbergen E; Bhigjee AI; Kamerman P; Ouma J; Raath R; Raff M; Salduker S;
    S Afr Med J; 2012 Mar; 102(5):312-25. PubMed ID: 22554341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options in postherpetic neuralgia.
    Bonezzi C; Demartini L
    Acta Neurol Scand Suppl; 1999; 173():25-35; discussion 48-52. PubMed ID: 10819089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathic pain: Review of mechanisms and pharmacologic management.
    Orza F; Boswell MV; Rosenberg SK
    NeuroRehabilitation; 2000; 14(1):15-23. PubMed ID: 11455064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.
    Bates N; Bello JK; Osazuwa-Peters N; Sullivan MD; Scherrer JF
    Curr Treat Options Oncol; 2022 Mar; 23(3):348-358. PubMed ID: 35254595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographics, assessment and management of pain in the elderly.
    Davis MP; Srivastava M
    Drugs Aging; 2003; 20(1):23-57. PubMed ID: 12513114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
    Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
    BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
    Lunn MP; Hughes RA; Wiffen PJ
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007115. PubMed ID: 24385423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuropathic pain due to malignancy: mechanisms, clinical manifestations and therapy].
    Pjević M; Patarica-Huber E; Radovanović D; Vicković S
    Med Pregl; 2004; 57(1-2):33-40. PubMed ID: 15327188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
    Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
    J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
    Kiss G
    Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
    Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
    Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
    Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
    BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a clinical pharmacy consult service on guideline adherence and management of gabapentin for neuropathic pain.
    Winterbottom LM; Fong AM; Benkstein KL; Liang B; Snodgrass LS; Parks-Huitron H
    J Manag Care Pharm; 2006; 12(1):61-9. PubMed ID: 16420109
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.